Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew McElroy

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Endourology|July 8, 2014
Editorial comment for Sim et alAndrew McElroy, Robert J Stein
Cureus|April 21, 2022
Increasing Compliance of Deep Vein Thrombosis Medical Prophylaxis in Acute Inpatient Rehabilitation SettingJun Zhang, Olga Komargodski, Andrew McElroy, et al.
Cureus|February 13, 2024
Correction: Increasing Compliance of Deep Vein Thrombosis Medical Prophylaxis in Acute Inpatient Rehabilitation SettingJun Zhang, Olga Komargodski, Andrew McElroy, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2008
Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agentsSimon Bailey, Paul V Fish, Stephane Billotte, et al.
Urologic Oncology|November 16, 2024
The use of nephron-sparing intervention does not appear to be compromised after a period of active surveillance for patients with cT1 renal massesMichael Wang, Aaron Wilke, Samuel Goorman, et al.
Journal of Medicinal Chemistry|June 27, 2007
Potent and selective nonpeptidic inhibitors of procollagen C-proteinasePaul V Fish, Gillian A Allan, Simon Bailey, et al.
Trials|February 17, 2022
The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19Leila Atmowihardjo, Job R Schippers, Imke H Bartelink, et al.
Critical Care (London, England)|June 8, 2023
Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trialLeila N Atmowihardjo, Job R Schippers, Erik Duijvelaar, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Endourology|July 8, 2014
Editorial comment for Sim et alAndrew McElroy, Robert J Stein
Cureus|April 21, 2022
Increasing Compliance of Deep Vein Thrombosis Medical Prophylaxis in Acute Inpatient Rehabilitation SettingJun Zhang, Olga Komargodski, Andrew McElroy, et al.
Cureus|February 13, 2024
Correction: Increasing Compliance of Deep Vein Thrombosis Medical Prophylaxis in Acute Inpatient Rehabilitation SettingJun Zhang, Olga Komargodski, Andrew McElroy, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2008
Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agentsSimon Bailey, Paul V Fish, Stephane Billotte, et al.
Urologic Oncology|November 16, 2024
The use of nephron-sparing intervention does not appear to be compromised after a period of active surveillance for patients with cT1 renal massesMichael Wang, Aaron Wilke, Samuel Goorman, et al.
Journal of Medicinal Chemistry|June 27, 2007
Potent and selective nonpeptidic inhibitors of procollagen C-proteinasePaul V Fish, Gillian A Allan, Simon Bailey, et al.
Trials|February 17, 2022
The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19Leila Atmowihardjo, Job R Schippers, Imke H Bartelink, et al.
Critical Care (London, England)|June 8, 2023
Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trialLeila N Atmowihardjo, Job R Schippers, Erik Duijvelaar, et al.
Pageof 1